electroCore, Inc. Announces Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering
28 Junho 2018 - 12:45PM
electroCore, Inc. (“electroCore”) (Nasdaq:ECOR) today announced
that the underwriters of its previously announced initial public
offering of common stock have exercised in full their option to
purchase an additional 780,000 shares of common stock from
electroCore at the initial public offering price of $15.00 per
share, less underwriting discounts and commissions. Including
exercise of the option, electroCore issued a total of 5,980,000
shares, resulting in aggregate proceeds of approximately
$83,421,000, net of underwriting discounts and commissions. All
shares of common stock in the offering were sold by electroCore.
electroCore’s common stock trades on the Nasdaq Global Select
Market under the symbol ECOR.
Evercore ISI, Cantor Fitzgerald & Co. and JMP Securities
acted as joint book-running managers for the offering. BTIG, LLC
acted as lead manager.
A registration statement related to these securities has been
filed with the U.S. Securities and Exchange Commission (SEC) and
was declared effective by the SEC the on June 21, 2018. Copies of
the registration statement may be accessed through the SEC’s
website at www.sec.gov.
The offering was made only by means of a prospectus forming part
of the registration statement. Copies of the final prospectus
related to the offering may be obtained from: Evercore ISI,
Attention: Equity Capital Markets, 55 East 52nd Street, 36th Floor,
New York, NY 10055, by phone at (888) 474-0200, or by email at
ecm.prospectus@evercore.com; Cantor Fitzgerald & Co., Attn:
Capital Markets, 499 Park Avenue, 5th Floor, New York, NY 10022, or
by phone at (212) 829-7122, or by email at prospectus@cantor.com;
or JMP Securities LLC, 600 Montgomery Street, 11th Floor, San
Francisco, California 94111, or by phone at (415) 835-8985, or by
email at syndicate@jmpsecurities.com.
This press release shall not constitute an offer to sell or a
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such an
offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such state or
jurisdiction. About electroCoreelectroCore, Inc.
is a commercial-stage bioelectronic medicine company dedicated to
improving patient outcomes through its platform non-invasive vagus
nerve stimulation therapy initially focused on the treatment of
multiple conditions in neurology and rheumatology. The company’s
initial targets are the acute treatment of migraine and episodic
cluster headache.
Contacts
Investors:Greg Chodaczek or Lynn LewisGilmartin
Groupinvestors@electrocorellc.com(610) 368-6505
or
Media:Alexandra Canale GCI Health(617)
921-9353alexandra.canale@gcihealth.com
electroCore (NASDAQ:ECOR)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
electroCore (NASDAQ:ECOR)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024